Richard T Maziarz Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

11/2023	Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
9/2022	Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States.
1/2022	Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.
1/2022	Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
1/2022	Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma.
10/2021	Lifetime Costs for Treated Follicular Lymphoma Patients in the US.
1/2021	Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
1/2021	Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies.
11/2020	Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
1/2020	The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard T Maziarz Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 09/2004
26	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 04/2004
22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2006
20	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 08/2003
19	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 11/2008
17	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2024 - 09/2004
16	Leukemia 01/2022 - 02/2006
13	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2008
13	Multiple Myeloma 01/2018 - 04/2009
11	Lymphoma (Lymphomas) 01/2023 - 04/2003
9	Infections 12/2023 - 03/2004
9	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2018
8	Bronchiolitis Obliterans Syndrome 01/2023 - 05/2009
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2015 - 09/2003
6	Cytokine Release Syndrome 12/2023 - 01/2019
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2003
5	Disease Progression 10/2021 - 05/2012
4	Nausea 05/2023 - 05/2003
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 03/2014
4	Injection Site Reaction 12/2013 - 06/2009
4	Invasive Fungal Infections 09/2013 - 05/2003
3	Vomiting 05/2023 - 05/2003
3	Bone Marrow Failure Disorders 12/2021 - 01/2009
3	Diarrhea 01/2021 - 05/2003
3	Blast Crisis (Blast Phase) 10/2020 - 04/2004
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2015 - 12/2004
3	Hodgkin Disease (Hodgkin's Disease) 03/2014 - 11/2008
3	Primary Myelofibrosis (Myelosclerosis) 01/2014 - 03/2010
2	cell-associated neurotoxicity 01/2023 - 10/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 04/2011
2	Communicable Diseases (Infectious Diseases) 02/2021 - 01/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 05/2007
2	Opportunistic Infections (Opportunistic Infection) 01/2020 - 01/2010
2	Pain (Aches) 01/2019 - 06/2004
2	Residual Neoplasm 01/2019 - 03/2006
2	Hematologic Diseases (Blood Diseases) 11/2017 - 07/2013
2	Neutropenia 09/2017 - 12/2013
2	Thrombocytopenia (Thrombopenia) 09/2017 - 10/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 11/2003
2	Mycoses (Diseases, Fungus) 09/2013 - 05/2003
2	Pathologic Complete Response 07/2013 - 02/2012
2	Splenomegaly 03/2013 - 09/2012
2	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2013 - 11/2008
2	Tumor Lysis Syndrome 09/2010 - 09/2004
2	Philadelphia Chromosome 09/2006 - 04/2004
1	Hemoglobinopathies 01/2023
1	Herpesviridae Infections (Herpesvirus Infection) 01/2022
1	Viremia 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Cytopenia 12/2021
1	Hyperferritinemia 12/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2021

Drug/Important Bio-Agent (IBA)

17	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2019
14	tisagenlecleucelIBA 01/2023 - 01/2019
13	fludarabineIBA 01/2023 - 12/2004
10	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 04/2006
8	plerixafor FDA Link 01/2018 - 06/2009
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 12/2008
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2013
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2021 - 04/2006
5	Busulfan (Busulfex)FDA Link 01/2019 - 12/2013
5	Imatinib Mesylate (Gleevec)FDA Link 10/2008 - 04/2004
4	axicabtagene ciloleucelIBA 01/2023 - 01/2020
4	Calcineurin InhibitorsIBA 01/2022 - 01/2015
3	tocilizumab (atlizumab)FDA Link 11/2020 - 01/2020
3	Rituximab (Mabthera)FDA Link 01/2020 - 10/2015
3	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 03/2014
3	Fluconazole (Zonal)FDA LinkGeneric 09/2013 - 05/2003
2	trans-crotonin (CTN)IBA 01/2024 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 06/2004
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 02/2006
2	Bortezomib (Velcade)FDA Link 01/2018 - 10/2014
2	AntigensIBA 01/2018 - 08/2012
2	Lenalidomide (CC 5013)FDA Link 09/2017 - 05/2012
2	treosulfanIBA 04/2014 - 03/2011
2	SteroidsIBA 02/2014 - 09/2004
2	Voriconazole (Vfend)FDA LinkGeneric 09/2013 - 12/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2007 - 04/2006
1	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2023
1	netupitantIBA 05/2023
1	Palonosetron (Aloxi)FDA Link 05/2023
1	EmeticsIBA 05/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Clofarabine (Clolar)FDA Link 01/2021
1	midostaurinIBA 01/2021

Therapy/Procedure

59	Cell Transplantation 01/2024 - 04/2004
51	Therapeutics 12/2023 - 04/2004
29	Transplantation 12/2023 - 04/2003
24	Hematopoietic Stem Cell Transplantation 03/2024 - 05/2003
16	Stem Cell Transplantation 10/2021 - 08/2003
13	Drug Therapy (Chemotherapy) 05/2023 - 06/2004
13	Homologous Transplantation 01/2021 - 04/2009
3	Autologous Transplantation 07/2013 - 02/2006
3	Hematopoietic Stem Cell Mobilization 04/2013 - 10/2009
2	Haploidentical Transplantation 12/2024 - 01/2022
2	Length of Stay 12/2023 - 01/2023
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2004 - 04/2003
1	Liver Transplantation 12/2021